We have located links that may give you full text access.
Journal Article
Review
Coronary revascularization in patients with end-stage renal disease: risks, benefits, and optimal strategies.
Patients with end-stage renal disease (ESRD) are at increased risk of death from cardiac causes. Traditionally, coronary artery disease (CAD) in this patient population has been treated conservatively. Despite the scope and complexity of the problem highlighted from large databases, there is a paucity of controlled, randomized data in patients with ESRD. In this paper we address the following two questions: 1) Should the patient with ESRD and CAD be treated with medical therapy or with mechanical revascularization? and 2) Which mechanical revascularization procedure is optimal- surgical or percutaneous? Although the mortality data in favor of coronary revascularization in patients with ESRD and clinically significant CAD is convincing, the data are based solely on retrospective analyses with relatively small numbers of patients. For now, the choice of the revascularization procedure itself must be individualized, taking into consideration such factors as comorbid conditions, coronary anatomy, and the likelihood of achieving complete revascularization. Data from large, prospective, randomized controlled trials are desperately needed to appropriately address the optimal application of coronary revascularization in patients with ESRD.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app